PD has different regulatory effects on p-Akt in various tissue types (17–20), and our in vitro results confirmed that low concentration of PD (about 0.2 IC50) inhibited p-Akt in KRAS-mutant CRC cells. The gene discussed is AKT1; the disease is colorectal carcinoma.